Rob has 17 years of biopharma business development and pipeline commercial experience with Lilly, Abbott and AbbVie that provides the PAASP team with an in-depth understanding of how biopharma companies evaluate risk and make decisions to optimise their pipelines with internal and external innovation:
- New product commercial development and for over 40 neuroscience programs
- Commercial forecasts and valuations for over 25 licensing/acquisition assessments
- Market research projects with over 1,500 HCPs, 300 patients and 250 payers
Rob’s commercial experience also includes seven years of medical product sales and account management with Baxter Healthcare plus account-based consulting and sales with health information firm Sachs Group / Solucient. As a Regional Director Rob managed licensing agreements with large US health systems and academic medical centers. Account based sales and licensing agreements are directly relevant for expanding the PAASP customer base and increasing revenue.
In addition to his current leadership role with PAASP Rob provides early stage commercial strategy consulting for start-ups and over 30 early discovery research teams.